Noureddine Ben Khalaf


Biochemist/ Molecular Biologist
Scientist with a strong background in Biochemistry, Molecular Biology and Structural Bioinformatics, I have over 10 years of research and development experience in translational medicine and health biotechnology. I worked since 2004 as a R&D engineer in the Institute Pasteur of Tunis, followed by a Master and PhD, I started an academic experience as an Assistant Professor and Associate Researcher at Pasteur Institute. My main focus was on parasite-host interaction studies to further understand parasite virulence mechanisms and identify new drug target for leishmaniasis. In 2009, I had the opportunity to work as an Invited Scientist at the University of California in San Francisco, in the Center for Discovery and Innovation in Parasitic Diseases (CDIPD) and Small Molecules Discovery Center (SMDC), where I run a project on High-throughput screening for anti-leishmanial drug discovery. In 2008, I co-founded a start-up company in Tunisia under the name of “CarthaGenomics Advanced Technologies”, a biotechnology company working in the field of DNA technologies. I was a consulting engineer providing scientific support to our different partners on specific research projects involving DNA technologies (gene silencing, diagnostics, drug discovery). Actually, I am a Postdoctoral Fellow at Al-Jawhara Center for Molecular Medicine and Inherited Diseases.

Biochemistry Bioengineering Bioinformatics Biotechnology Computational Biology Drugs & Devices Molecular Biology

Institution affiliations

Work details

Postdoctoral Fellow

Arabian Gulf University
September 2013
AlJawhara Center for Molecular Medicine
I am a Postdoctoral Fellow at Al-Jawhara Center for Molecular Medicine and Inherited Diseases and a Tutor in the Molecular Medicine Department of the College of Medicine in The Arabian Gulf University in Bahrain, my main focus is on developing new protein engineering approaches using molecular modeling. I am involved in several research projects covering different aspects of therapeutic discovery, including antibody engineering and chimera proteins design for autoimmune diseases and cancer therapeutics. I have authored 08 papers published in International peer-reviewed Journals and participated to several International Conferences and Workshops. I supervised several research projects including Biotechnology Engineers, Masters’, and Ph.D.


PeerJ Contributions